| Literature DB >> 31693905 |
Philip Dusart1, Björn Mikael Hallström2, Thomas Renné3, Jacob Odeberg4, Mathias Uhlén2, Lynn Marie Butler5.
Abstract
Changes in the endothelium of the cerebral vasculature can contribute to inflammatory, thrombotic, and malignant disorders. The importance of defining cell-type-specific genes and their modification in disease is increasingly recognized. Here, we develop a bioinformatics-based approach to identify normal brain cell-enriched genes, using bulk RNA sequencing (RNA-seq) data from 238 normal human cortex samples from 2 independent cohorts. We compare endothelial cell-enriched gene profiles with astrocyte, oligodendrocyte, neuron, and microglial cell profiles. Endothelial changes in malignant disease are explored using RNA-seq data from 516 lower-grade gliomas and 401 glioblastomas. Lower-grade gliomas appear to be an "endothelial intermediate" between normal brain and glioblastoma. We apply our method for the prediction of glioblastoma-specific endothelial biomarkers, providing potential diagnostic or therapeutic targets. In summary, we provide a roadmap of endothelial cell identity in normal and malignant brain, using a method developed to resolve bulk RNA-seq into constituent cell-type-enriched profiles.Entities:
Keywords: RNA-seq; brain; cell identity; endothelial cells; gene expression; glioblastoma; tumor vasculature
Mesh:
Substances:
Year: 2019 PMID: 31693905 DOI: 10.1016/j.celrep.2019.09.088
Source DB: PubMed Journal: Cell Rep Impact factor: 9.423